TP53 and cancer: Comprehensive studies have been performed with repurposed protoporphyrin IX (PpIX) and the analog, verteporfin (VP), both approved by the FDA for the treatment of non-oncological human diseases, revealing the reactivation of p53 and p73 in cancer cells without affecting normal cells [111,112].